What is a stock summary page? Click here for an overview.
Bristol-Myers Squibb Co (NYSE:BMY) Stock News, Headlines & Updates
Bristol-Myers Squibb Co Stock News from GuruFocus
- 1
- 2
Apr 25, 2025
Bristol Myers (BMY) Price Target Reduced by UBS Despite Strong Performance | BMY Stock News
GuruFocus News • 8:18am
Bristol Myers (BMY) Price Target Raised by BofA Analyst Following Solid Q1 | BMY Stock News
GuruFocus News • 7:35am
Bristol Myers (BMY) Faces Lowered Price Target Amid Growth Concerns | BMY Stock News
GuruFocus News • 6:25am
Decoding Bristol-Myers Squibb Co (BMY): A Strategic SWOT Insight
GuruFocus News • 2:03am
Q1 2025 Bristol-Myers Squibb Co Earnings Call Transcript
GuruFocus News • 11:06pm
Apr 24, 2025
Bristol Myers Squibb (BMY) Reports Strong Q1 2025 Earnings and Guidance Upgrade
GuruFocus News • 11:57am
Bristol Myers Squibb (BMY) Surpasses Earnings and Revenue Estimates
GuruFocus News • 8:58am
Bristol-Myers Squibb (BMY) Surges After Beating Earnings Forecasts and Raising Outlook
GuruFocus News • 7:59am
Bristol-Myers Squibb (BMY) Q1 Earnings Exceed Expectations
GuruFocus News • 6:58am
Company Lifts Revenue Forecast for FY25, Announces Increased EPS Guidance | BMY Stock News
GuruFocus News • 6:35am
Bristol-Myers Squibb Q1 2025 Earnings: Revenue Surpasses Estimates at $11.2 Billion, GAAP EPS Meets Expectations at $1.20
GuruFocus News • 6:31am
Bristol Myers (BMY) Exceeds Q1 Revenue Expectations with Strong Performance | BMY Stock News
GuruFocus News • 6:16am
Bristol Myers Squibb Reports First Quarter Financial Results for 2025 | BMY Stock News
GuruFocus News • 6:15am
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
Business Wire • 6:00am
Apr 23, 2025
Bristol-Myers Squibb Co (BMY) Trading Down 4.11% on Apr 23
GuruFocus News • 12:06pm
Bristol-Myers Squibb (BMY) Q1 Earnings Preview: Key Factors to Watch
GuruFocus News • 11:55am
Bristol Myers (BMY) Faces Price Target Cut as Trial Results Disappoint | BMY Stock News
GuruFocus News • 6:49am
Bristol Myers (BMY) Faces Setback in Schizophrenia Drug Trial, Shares Still Rated 'Buy' | BMY Stock News
GuruFocus News • 6:48am
Apr 22, 2025
Bristol Myers Squibb (BMY) Shares Dip After Schizophrenia Drug Trial Misses Goal
GuruFocus News • 3:57pm
Bristol Myers (BMY) Shares Phase 3 Trial Results for Cobenfy in Schizophrenia | BMY Stock News
GuruFocus News • 3:48pm
Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schiz
GuruFocus News • 3:32pm
Bristol Myers (BMY) Sees Neutral Rating with $55 Price Target by Cantor Fitzgerald | BMY Stock News
GuruFocus News • 6:48am
Bristol Myers (BMY) Rated Overweight by Piper Sandler Amid Reinvention Efforts | BMY Stock News
GuruFocus News • 6:31am
Apr 21, 2025
Bristol Myers' Camzyos Update Boosts Prospects for Cytokinetics (CYTK) | BMY Stock News
GuruFocus News • 9:18am
Apr 18, 2025
Bristol Myers (BMY) Gains FDA Nod for Updated Camzyos Label to Simplify Treatment | BMY Stock News
GuruFocus News • 6:30am
Bristol-Myers Squibb Co (BMY) Announces FDA Updates for CAMZYOS Prescribing Information | BMY stock news
GuruFocus News • 8:03pm
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
Business Wire • 8:00pm
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications | BMY Stock News
GuruFocus News • 7:45pm
Apr 17, 2025
Bristol Myers (BMY) Target Price Trimmed as Revenue Projections Dip | BMY Stock News
GuruFocus News • 7:19am
Apr 15, 2025
Bristol Myers Squibb (BMY) Partners with Optellum for AI Lung Cancer Diagnosis
GuruFocus News • 5:55pm
BofA Adjusts Price Target for Cytokinetics (CYTK) Amid Competitive Developments | BMY Stock News
GuruFocus News • 7:46am
Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis | BMY Stock News
GuruFocus News • 7:19am
Apr 14, 2025
Bristol Myers Squibb (BMY) Sees Stock Dip as Camzyos Trial Falls Short
GuruFocus News • 4:55pm
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
Business Wire • 4:00pm
Bristol Myers (BMY) Reports Unmet Goals in Key Trial for Camzyos | BMY Stock News
GuruFocus News • 3:46pm
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial | BMY Stock News
GuruFocus News • 3:31pm
Apr 11, 2025
Bristol-Myers Squibb Co (BMY) Gains FDA Approval for Opdivo and Yervoy in Liver Cancer Treatment | BMY stock news
GuruFocus News • 4:03pm
Bristol Myers Squibb (BMY) Secures FDA Approval for Liver Cancer Treatment
GuruFocus News • 3:55pm
FDA Approves Bristol Myers' (BMY) Opdivo and Yervoy Combo for Advanced Liver Cancer | BMY Stock News
GuruFocus News • 3:15pm
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news